ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Mediha Ahmad
Matched on OpenAlex author ID A5003866924. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2013: 1 paper · 2014: 1 paper · 2015: 1 paper
Papers 3
- Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Co-author DOI 10.3109/0284186x.2014.1000466↗
- Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. Co-author DOI 10.1111/hpb.12154↗
- Intensifying local radiotherapy for pancreatic cancer-who benefits and how do we select them? First author DOI 10.3978/j.issn.2078-6891.2013.027↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sunil Krishnan · 3 shared papers, 2013–2015 · strength 0.15
- Paper Intensifying local radiotherapy for pancreatic cancer-who benefits and how do we select them? DOI 10.3978/j.issn.2078-6891.2013.027↗
- Paper Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. DOI 10.3109/0284186x.2014.1000466↗
- Paper Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline rese… DOI 10.1111/hpb.12154↗
- Matthew H. G. Katz · 2 shared papers, 2014–2015 · strength 0.08
- Paper Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. DOI 10.3109/0284186x.2014.1000466↗
- Paper Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline rese… DOI 10.1111/hpb.12154↗
- Robert A. Wolff · 2 shared papers, 2014–2015 · strength 0.08
- Paper Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. DOI 10.3109/0284186x.2014.1000466↗
- Paper Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline rese… DOI 10.1111/hpb.12154↗
- Jason B. Fleming · 2 shared papers, 2014–2015 · strength 0.08
- Paper Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. DOI 10.3109/0284186x.2014.1000466↗
- Paper Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline rese… DOI 10.1111/hpb.12154↗
- Gauri Rajani Varadhachary · 2 shared papers, 2014–2015 · strength 0.08
- Paper Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. DOI 10.3109/0284186x.2014.1000466↗
- Paper Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline rese… DOI 10.1111/hpb.12154↗
- Christopher H. Crane · 2 shared papers, 2014–2015 · strength 0.08
- Paper Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. DOI 10.3109/0284186x.2014.1000466↗
- Paper Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline rese… DOI 10.1111/hpb.12154↗
- Milind M. Javle · 1 shared paper, 2015 · strength 0.04
- Awalpreet Singh Chadha · 1 shared paper, 2015 · strength 0.04
- Sushovan Guha · 1 shared paper, 2015 · strength 0.04
- Aparna Balachandran · 1 shared paper, 2014 · strength 0.04
- Huamin Wang · 1 shared paper, 2014 · strength 0.04
- Jean‐Nicolas Vauthey · 1 shared paper, 2014 · strength 0.04
- Peter W. T. Pisters · 1 shared paper, 2014 · strength 0.04
- Jeffrey E. Lee · 1 shared paper, 2014 · strength 0.04
- Ching-Wei David Tzeng · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.